trending Market Intelligence /marketintelligence/en/news-insights/trending/knxn4latsn4vug4wklbjpg2 content esgSubNav
In This List

UK's Realm Therapeutics to list American depositary shares on Nasdaq

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


UK's Realm Therapeutics to list American depositary shares on Nasdaq

Realm Therapeutics PLC, a U.K. developer of topical medicines for skin conditions, is listing its American depositary shares on the Nasdaq Stock Market.

The ADSs will begin trading this month under the ticker RLM.

The London-based company will list 126,857,901 ordinary shares, represented by about 5,074,316 ADSs. Each ADS represents 25 ordinary shares, with a nominal value of 10 pence per share.

Realm said it will not receive proceeds from the transaction.